Regulation of CD8+ T cell responses via liver NK-DC crosstalk
通过肝脏 NK-DC 串扰调节 CD8 T 细胞反应
基本信息
- 批准号:7746094
- 负责人:
- 金额:$ 25.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-18 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus InfectionsAdenovirusesAffectAntigensAntiviral AgentsBiological ModelsBone MarrowCD8B1 geneCell physiologyCellsChimera organismCoupledFailureFoodGenerationsGoalsHepatitis C virusHepatocyteIL2RA geneImmuneImmune responseImmunityImmunizationImmunotherapeutic agentImpairmentInfectionInjection of therapeutic agentInjuryInterleukin-10LacZ GenesLinkLiverMediatingModelingMusNatural ImmunityNatural Killer CellsPhasePlayPoly I-CRecruitment ActivityRegulationReporterReportingRoleRouteSignal TransductionSiteSystemT cell regulationT-Cell ActivationT-LymphocyteTestingTherapeutic AgentsTissuesViral AntigensVirusVirus Diseasesbasecell typecytokinedesignin vivoinsightintrahepaticliver functionliver infectionlymph nodesreceptorresponse
项目摘要
The liver evolves mechanism(s) to dampen and possibly suppress the host immunity to nonpathogenic food
antigens. As a result, liver tropic viruses such as HCV establish the persistent infection in the liver due
impaired CD8+ T cell responses. NK cells are highly enriched in the liver and act as innate defense to viral
infection. Following conjugation between NK cells and target cells, NK cells are activated and express NK
activating/inhibitory receptors to trigger NK activity. Signaling through intimate interaction of NK
activation/inhibitory receptors is critical for controlling NK activities. NK cells have been reported to play a
pivotal role in linking innate immunity to adaptive immunity, particularly regulation of intrahepatic CDS* T cell
responses during viral infection.
We have recently established a murine model system via two different routes (i.e. IV vs SubQ) of adenovirus
infection, which is an important system to dissect the mechanism for regulation of intrahepatic CD8+ T cell
responses. IV inoculation predominantly delivers viral antigen to the liver while SubQ injection expresses
antigen into the lymph nodes. By employing this murine model, we found that different route of adenovirus
infection influence the magnitude and effector function of CDS* T cell responses. The impaired CDS* T cell
responses were found in the liver of mice following IV infection. In contrast, mice infected SubQ adenovirus
infection generates the effective CDS* T cell responses. In addition, NKG2A*NK cells and IL-10-producing
DC are increased in the liver from IV Ad-LacZ infected mice. Intriguingly, the in vivo depletion of NK cells
reversed the dysregulation of antiviral CDS* T cell responses.
These results, coupled with evidence that the inhibitory function of liver NK cells, suggest a potential
mechanism for NK cell-mediated in inhibition of CDS* T cell effector function via NK-DC cross-talk. In this
proposal, we will characterize the effect of NK cells on affecting CDS* T cell responses and determine the
mechanism for NK-mediated impairment of CDS* T cell effector function via altering DC activation. These
studies may provide a useful information regarding the regulatory role of NK cell dysregulation in generation
of effective CDS* T cell responses as well as new insights for immunotherapeutic strategies against viral
infection.
肝脏进化出一种机制来抑制宿主对非致病性食物的免疫力
抗原因此,嗜肝病毒如HCV在肝脏中建立持续感染,
受损的CD 8 + T细胞应答。NK细胞在肝脏中高度富集,并充当对病毒的先天防御。
感染在NK细胞和靶细胞之间接合之后,NK细胞被激活并表达NK细胞。
激活/抑制受体以触发NK活性。通过NK的密切相互作用的信号传导
活化/抑制受体对于控制NK活性至关重要。据报道,NK细胞发挥了
在连接先天性免疫与适应性免疫,特别是调节肝内CDS* T细胞中的关键作用
病毒感染时的反应。
我们最近通过两种不同的腺病毒途径(即IV与SubQ)建立了小鼠模型系统
感染是研究肝内CD 8 + T细胞调节机制的重要系统
应答IV接种主要将病毒抗原递送至肝脏,而SubQ注射表达
抗原进入淋巴结。通过使用这种小鼠模型,我们发现不同途径的腺病毒
感染影响CDS* T细胞应答的幅度和效应子功能。受损的CDS* T细胞
在IV感染后小鼠的肝脏中发现了应答。相反,小鼠感染SubQ腺病毒,
感染产生有效的CDS* T细胞应答。此外,NKG 2A *NK细胞和产生IL-10的
DC在IV Ad-LacZ感染小鼠的肝脏中增加。有趣的是,体内NK细胞的消耗
逆转了抗病毒CDS* T细胞应答的失调。
这些结果,再加上证据表明,肝脏NK细胞的抑制功能,表明一个潜在的
NK细胞介导的通过NK-DC串扰抑制CDS* T细胞效应子功能的机制。在这
我们将描述NK细胞对影响CDS* T细胞应答的作用,并确定NK细胞对CDS* T细胞应答的影响。
NK介导的CDS* T细胞效应子功能受损的机制通过改变DC活化。这些
研究可能会提供一个有用的信息,关于NK细胞失调的调节作用,
有效的CDS* T细胞反应以及针对病毒的免疫策略的新见解
感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Young S. Hahn其他文献
Young S. Hahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Young S. Hahn', 18)}}的其他基金
Role of HCV exosomes in intercellular communication
HCV 外泌体在细胞间通讯中的作用
- 批准号:
10549367 - 财政年份:2020
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV exosomes in intercellular communication
HCV 外泌体在细胞间通讯中的作用
- 批准号:
10833764 - 财政年份:2020
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV exosomes in intercellular communication
HCV 外泌体在细胞间通讯中的作用
- 批准号:
10360522 - 财政年份:2020
- 资助金额:
$ 25.51万 - 项目类别:
Control of Influenza Infection by Lipid Mediators and Macrophages
通过脂质介质和巨噬细胞控制流感感染
- 批准号:
10317033 - 财政年份:2018
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV in aberrant APC activation/function
HCV 在异常 APC 激活/功能中的作用
- 批准号:
8678833 - 财政年份:2012
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV in aberrant APC activation/function
HCV 在异常 APC 激活/功能中的作用
- 批准号:
8468021 - 财政年份:2012
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV in aberrant APC activation/function
HCV 在异常 APC 激活/功能中的作用
- 批准号:
8860103 - 财政年份:2012
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV in aberrant APC activation/function
HCV 在异常 APC 激活/功能中的作用
- 批准号:
8371025 - 财政年份:2012
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV in aberrant APC activation/function
HCV 在异常 APC 激活/功能中的作用
- 批准号:
9095220 - 财政年份:2012
- 资助金额:
$ 25.51万 - 项目类别:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
HCV* 肝细胞在抗病毒 T 细胞免疫调节中的作用
- 批准号:
7919878 - 财政年份:2005
- 资助金额:
$ 25.51万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 25.51万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 25.51万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 25.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 25.51万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 25.51万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 25.51万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 25.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 25.51万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 25.51万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 25.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)